Expert consensus on personalized initiation of glucose‐lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease

医学 2型糖尿病 疾病 肾脏疾病 重症监护医学 糖尿病 内科学 生物信息学 心脏病学 内分泌学 生物
作者
Fang Zhang,Linong Ji,Tianpei Hong,Lixin Guo,Yan Li,Zhiming Zhu,Xingbin Liu,Fang Liu,Lizhi Tang,Yuwei Zhang,Juan Li,Qingguo Lü,Nanwei Tong
出处
期刊:Journal of Evidence-based Medicine [Wiley]
卷期号:15 (2): 168-179 被引量:6
标识
DOI:10.1111/jebm.12474
摘要

Abstract Since it is difficult for clinicians to make a decision among the various types of antidiabetic medications due to their great discrepancy in mechanisms, pharmacological properties, and cardiovascular/renal protection, a relatively “precision” or personalized hypoglycemic treatment suggestion is practical for type 2 diabetes (T2D) management in adults. This expert consensus makes some recommendations based on the characteristics of adult T2D patients without clinical cardiovascular disease (CVD) or chronic kidney disease (CKD) by evidence from large‐scale clinical trials. The main consideration for initiating antidiabetic medications is the safety and benefits for prevention of target organ damage, such as CVD and CKD. The choice of personalized glucose‐lowering therapy regarding target organ protection is based on the various effects of antidiabetic medications, patients’ clinical characteristics and their key risks, as well as the sociological factors. According to the effects on glucose reduction, cardiovascular protection, renal benefit, body weight change, hypoglycemic risk, and liver function impact, the antidiabetic medications are recategorized in this consensus. Combined with the glucose control target and the different effects of hypoglycemic agents, a significant body of recommendations have been developed for optimal T2D management according to the risk factors for atherosclerotic CVD, heart failure, CKD, primary fatty liver, and hypoglycemia. This consensus gives detailed guidance on personalized antidiabetic therapy initiation in newly diagnosed T2D adults, which attaches great importance to both glucose control and target organ protection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
swimming发布了新的文献求助10
刚刚
Owen的应助被zhhyi1976采纳,获得10
1秒前
Leisle发布了新的文献求助30
2秒前
2秒前
李健的应助被燎原十八拍采纳,获得10
2秒前
Yuan88发布了新的文献求助10
3秒前
玩命的小虾米完成签到,获得积分10
3秒前
3秒前
4秒前
初景发布了新的文献求助10
4秒前
5秒前
敏感墨镜发布了新的文献求助10
6秒前
顺利毕业发布了新的文献求助10
6秒前
Leexxxhaoo完成签到,获得积分10
6秒前
上官若男的应助被徐枘采纳,获得10
6秒前
7秒前
1111发布了新的文献求助10
7秒前
Yuan88发布了新的文献求助10
7秒前
公爵发布了新的文献求助10
7秒前
科目三的应助被木木采纳,获得10
8秒前
8秒前
Maestro_S的应助被现代海蓝采纳,获得10
8秒前
zzz完成签到 ,获得积分10
9秒前
123发布了新的文献求助10
9秒前
9秒前
Leexxxhaoo发布了新的文献求助10
9秒前
10秒前
Lucas的应助被活泼的鼠标采纳,获得10
10秒前
清脆香露发布了新的文献求助10
10秒前
11秒前
动听寻雪发布了新的文献求助10
11秒前
顾矜的应助被sunshine采纳,获得10
11秒前
11秒前
SciGPT的应助被waiting采纳,获得10
12秒前
12秒前
12秒前
12秒前
李洋完成签到,获得积分10
13秒前
Yuan88发布了新的文献求助10
14秒前
可玩性完成签到 ,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184220
求助须知:如何正确求助?哪些是违规求助? 9573266
关于积分的说明 21830447
捐赠科研通 7781246
什么是DOI,文献DOI怎么找? 3434248
关于科研通互助平台的介绍 2558373
邀请新用户注册赠送积分活动 2480784